• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: HOYA SURGICAL OPTICS, INC. NC1-SP; INTRAOCULAR LENS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

HOYA SURGICAL OPTICS, INC. NC1-SP; INTRAOCULAR LENS Back to Search Results
Model Number NC1-SP (+19.50 D)
Device Problems Optical Distortion (3000); Appropriate Term/Code Not Available (3191)
Patient Problem Insufficient Information (4580)
Event Date 08/23/2022
Event Type  Injury  
Manufacturer Narrative
This initial and final emdr is being submitted to fda for a reportable event that occurred outside the usa.Posterior capsule opacification (pco) is indicated as a potential adverse event related to iol implantation as covered under the warnings section of the product's instructions for use (ifu).The product was not returned to the manufacturer.The investigation was conducted, with the methods and results as noted below.No abnormalities were found in production and inspection records of the product.(serial no.: (b)(4) model: nc1-sp).There were no abnormalities on the sterilization records of the lot.(eq026).Exact root cause was not determined.However, from our investigation, we believe the event is not related to our product quality.A review of the most recent complaint trending data indicates that no significant trends have been identified at this time and no capa is required as part of the product evaluation.
 
Event Description
Event reported in austria.Post-operative complications - pco.Reported as 9 months after implantation.Patient impact: unknown; insufficient information.
 
Manufacturer Narrative
This follow-up #1 emdr is being submitted to fda for a reportable event that occurred outside the usa.Event occurred in austria and was initially assessed as a reportable event based on the available reported information.After an individual medical assessment was conducted, corrections to the initial report were noted as outlined below.Updated information as of (b)(6) 2022 indicated that no negative impact on the patient's health occurred.The patient had expressed concerns about avoiding a pco after his recent iol implantation.Therefore, the event has been re-assessed as not reportable in austria, the country of origin.
 
Event Description
Event reported in austria.Date of implant - not provided.Post-operative complications - pco.Reported as 9 months after implantation.Patient impact: unknown; insufficient information.(b)(6) 2022 updated information with reportability reassessed to not reportable in austria, as noted below.Post operative complications, after-cataract, were previously reported.(b)(6) 2022: the case will be assessed non-reportable as no patient impact was reported and the main patient's questions and concern had been addressed by individual medical assessment.Per individual medical assessment: the patient's main concern was about avoiding a pco after his recent iol implantation.This concern was addressed.Pco is a known potential ae and treatable.No negative impact on patient's health was reported.Malfunctions and defects of the devices are being monitored.All trends, when observed, are and will be reported.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
NC1-SP
Type of Device
INTRAOCULAR LENS
Manufacturer (Section D)
HOYA SURGICAL OPTICS, INC.
525 technology drive
suite 280
irvine CA 92618
Manufacturer (Section G)
HOYA MEDICAL SINGAPORE PTE LTD
455a jalan ahmad ibrahim
singapore, singapore 63993 9
SN   639939
Manufacturer Contact
goutham pendyala
525 technology drive
suite 280
irvine, CA 92618
9093896317
MDR Report Key15407526
MDR Text Key299761501
Report Number3006723646-2022-00134
Device Sequence Number1
Product Code HQL
Combination Product (y/n)N
Reporter Country CodeAU
PMA/PMN Number
P080004
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Consumer,Company Representative
Reporter Occupation Other
Type of Report Initial,Followup
Report Date 08/23/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received09/12/2022
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date01/31/2023
Device Model NumberNC1-SP (+19.50 D)
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? No
Date Manufacturer Received08/23/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured01/31/2020
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other;
-
-